Back to top

AVEO Pharmaceuticals, Inc. (AVEO) Catches Eye: Stock Rises 8%
December 31, 2013

Read MoreHide Full Article

AVEO Pharmaceuticals, Inc. (AVEO - Free Report) was a big mover last session, as the company saw its shares rise by 8% on the day. This gain can be attributable to solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend of the company as the stock is now down 17.8% in the past one-month time frame.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate has remained static. However, yesterday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.

AVEO Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

However, some better-ranked stocks in the healthcare industry include Heska Corporation (HSKA - Free Report) , Forest Laboratories Inc. and Jazz Pharmaceuticals plc (JAZZ - Free Report) , all with a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AVEO Pharmaceuticals, Inc. (AVEO) - free report >>

Jazz Pharmaceuticals PLC (JAZZ) - free report >>

Heska Corporation (HSKA) - free report >>

More from Zacks Tale of the Tape

You May Like